Zdrowie i gospodarka · 14/10/2022

FDA Releases Final Guidance on Postapproval Changes to Drug Applications

The Food and Drug Administration (FDA) has released a final guidance to help pharmaceutical companies implement postapproval changes to their drug applications, which can streamline the process and improve the quality of manufacturing, ultimately leading to faster distribution of products and enhanced supply chain management.